ÂÜÀòÂÒÂ×

Théo Risopoulos has extensive work experience in the investment industry. Théo is currently a General Partner at Theodorus Investment Funds since June 2023. Prior to this role, they served as a Principal from July 2021 to June 2023, an Investment Manager from February 2020 to July 2021, and an Investment Associate from July 2018 to February 2020 at the same company.

Additionally, Théo has held positions as an Early-stage Investor at Flare and Domain Therapeutics since November 2022 and May 2022 respectively. Théo also serves as a Board Director at DrugBank since April 2022. In 2021, they worked as a Mentor at Front Row Ventures and NextAI, and as a Board Observer at Classcraft.

Théo's earlier experience includes a role as a Board Observer at Icentia Inc. starting in February 2020 and as a Board Director at Calyos starting in December 2018. Additionally, they served as an Early-stage Investor at Moonshot Health from May 2019 to May 2021.

Théo Risopoulos has a diverse and extensive education history. In 2011, they began their undergraduate studies at Solvay Brussels School of Economics and Management, where they pursued a Bachelor's degree in Applied Economics - Management Science. Théo completed their bachelor's degree in 2014.

During their undergraduate studies, Théo also participated in a summer program on Portfolio Management Theory at Utrecht University in 2013.

Following their bachelor's degree, Théo pursued further education in the field of finance. In 2014, they enrolled in a Master's degree program in Quantitative Techniques for Economics and Management (QTEM) at Solvay Brussels School of Economics and Management. Théo completed this program in 2016, with a major in Finance and Risk Management.

During their Master's degree program, Théo also participated in two QTEM partner programs. In 2014-2015, they attended Monash University for a Master's in Applied Finance, and in 2015-2016, they attended EDHEC Business School for a Master of Science (M.S.) in Financial Markets, with a minor in Asset Management.

To further expand their knowledge and skills, Théo has also pursued various certifications and courses. Théo completed an Executive Education program at Harvard Business School in Private Equity and Venture Capital in 2023. Théo also obtained several certifications through online platforms like Coursera, including Introduction to the Biology of Cancer from Johns Hopkins University, Stories of Infection from Stanford University, Advanced Neurobiology I from Beijing University, Design and Interpretation of Clinical Trials from Johns Hopkins University, Financing and Investing in Infrastructure from Bocconi University, Private Equity and Venture Capital from Bocconi University, Financial Engineering and Risk Management Parts I and II from Columbia University, and Lean in manufacturing and services from École des Ponts ParisTech & BCG.

Additionally, Théo has obtained the Certified Lean Six Sigma Green Belt certification from CUBIK Partners in 2017. Théo has also participated in various business competitions, including the Solvay Business Game in 2016 and the BCG Strategy Cup in 2014, where they achieved notable rankings and recognition.

Théo's education history showcases their strong commitment to continuous learning and their exploration of various fields within finance and management.